| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00005792-199209000-00004 |
| P698 | PubMed publication ID | 1522805 |
| P50 | author | Michelle A. Petri | Q67485110 |
| P2093 | author name string | M. Petri | |
| D. Spence | |||
| M. C. Hochberg | |||
| L. R. Bone | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| coronary artery disease | Q844935 | ||
| P304 | page(s) | 291-302 | |
| P577 | publication date | 1992-09-01 | |
| P1433 | published in | Medicine | Q15716652 |
| P1476 | title | Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: prevalence, recognition by patients, and preventive practices | |
| P478 | volume | 71 |
| Q34364143 | A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy |
| Q39017583 | Association between ischemic heart disease and systemic lupus erythematosus-a large case-control study |
| Q34108806 | Atherosclerosis and systemic lupus erythematosus |
| Q37319989 | Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings |
| Q84430476 | Atherosclerosis risk factors in systemic lupus erythematosus |
| Q37690605 | Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events |
| Q44188219 | Atherosclerotic vascular disease in systemic lupus erythematosus. |
| Q36153524 | Cardiovascular Events in Systemic Lupus Erythematosus: A Nationwide Study in Spain From the RELESSER Registry |
| Q26823443 | Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure |
| Q93667201 | Cardiovascular disease and socioeconomic status |
| Q30560952 | Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort |
| Q80599578 | Coronary artery aneurysm with systemic lupus erythematosus |
| Q54943278 | Differential gene expression profiles in peripheral blood in Northeast Chinese Han people with acute myocardial infarction. |
| Q34037767 | Distribution of cardiovascular disease risk factors by socioeconomic status among Canadian adults |
| Q46979268 | Effect of detoxification, removing stasis and nourishing yin method on corticosteroid-induced hyperlipidemia in patients with systemic lupus erythematosus |
| Q33758208 | Factors associated with arterial vascular events in PROFILE: a Multiethnic Lupus Cohort |
| Q26774658 | High-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting Mechanisms |
| Q38863066 | Higher circulating levels of OxLDL % of LDL are associated with subclinical atherosclerosis in female patients with systemic lupus erythematosus |
| Q34487229 | Inflammatory expression profiles in monocyte-to-macrophage differentiation in patients with systemic lupus erythematosus and relationship with atherosclerosis. |
| Q88417091 | Influence of autoimmunity and inflammation on endothelial function and thrombosis in systemic lupus erythematosus patients |
| Q42866736 | Intestinal Angina Due to Atherosclerosis in a 45-year-old Systemic Lupus Erythematosus Patient |
| Q34037777 | Knowledge of cardiovascular disease risk factors among the Canadian population: relationships with indicators of socioeconomic status |
| Q33376538 | Lupus nephritis and Raynaud's phenomenon are significant risk factors for vascular thrombosis in SLE patients with positive antiphospholipid antibodies |
| Q33730536 | Management of cardiovascular complications in systemic lupus erythematosus |
| Q38889941 | Maternal-placental syndrome and future risk of accelerated cardiovascular events in Parous Swedish women with systemic lupus erythematosus - a population-based retrospective cohort study with time-to-event analysis |
| Q39550704 | Metabolic syndrome and insulin resistance comorbidity in systemic lupus erythematosus. Effect on carotid intima-media thickness |
| Q46901557 | Modern therapy for systemic lupus erythematosus |
| Q35636684 | Modification of hypertension and hypercholesterolaemia in patients with systemic lupus erythematosus: a quality improvement study |
| Q35552164 | Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus |
| Q38230699 | Pathogenesis and treatment of atherosclerosis in lupus |
| Q33448450 | Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort |
| Q51464078 | Prevalence and factors associated with dyslipoproteinemias in Brazilian systemic lupus erythematosus patients. |
| Q34627711 | Prevalence of LDL atherogenic phenotype in patients with systemic lupus erythematosus |
| Q40506590 | Prognosis in systemic lupus erythematosus |
| Q64926763 | Recognition and control of hypertension, diabetes, and dyslipidemia in patients with systemic lupus erythematosus. |
| Q33714074 | Risk of stroke in patients with rheumatism: a nationwide longitudinal population-based study. |
| Q24804985 | SLE - Practical and theoretical barriers to the prevention of accelerated atherosclerosis in systemic lupus erythematosus |
| Q31000488 | Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. |
| Q57985176 | Self-Reported Physical Activity Is Associated with Lupus Nephritis in Systemic Lupus Erythematosus: Data from KORean Lupus Network (KORNET) Registry |
| Q35650241 | Standard and alternative adjunctive treatments in cardiac rehabilitation |
| Q47610317 | The Use of Primary Prevention Statin Therapy in Those Predisposed to Atherosclerosis |
| Q36821493 | The role of preventive cardiology in systemic lupus erythematosus |
| Q81772558 | [Accelerated atherosclerosis in rheumatic systemic diseases as an example of systemic lupus erythematosus--what is the consequence?] |
| Q84815168 | [Changes in mortality and morbidity in systemic lupus erythematosus] |
| Q79566794 | [The heart in rheumatic diseases] |
Search more.